Biotech
-
AbbVie to Acquire ImmunoGen for $10.1 Billion, Adding Ovarian Cancer Drug Elahere
On a Wednesday in mid-November, AbbVie decided it would pay $10.1 billion for ImmunoGen. That is a lot of money for a…
-
Talquetamab Wins FDA Accelerated Approval, Then European Approval, for Relapsed Multiple Myeloma
United States, August 16, 2023 — cybernewschronicle.com — On August 15, 2023, the medical community marked a significant milestone with the approval…
-
FDA Grants Accelerated Approval to Elrexfio for Heavily Treated Multiple Myeloma
/ HTML. So we need headings maybe and paragraphs . Must not add any extra info. Must keep facts: FDA approved Elranatamab…
-
Swiss Brain Implant Allows Paralyzed Man to Walk Naturally
On May 24, 2023, researchers in Switzerland announced a significant medical milestone. A man who had been paralyzed regained the ability to…
-
FDA Approves Adstiladrin, First Gene Therapy for BCG-Unresponsive Bladder Cancer
United States, December 20, 2022 — cybernewschronicle.com — Nadofaragene firadenovec, a gene therapy marketed under the brand name Adstiladrin, has been approved…
-
Arcturus Therapeutics Receives Funding For Vaccine Development Efforts
The first tranche of Singapore’s $10 million grant arrived in Arcturus Therapeutics’ accounts on March 9, delivering $3 million that the company…
-
Moderna Ships New Vaccine to Test Third Dose Against B.1.351 Variant
On 26 February 2020, a modest consignment departed Moderna’s Cambridge, Massachusetts plant carrying vials of the experimental vaccine mRNA‑1273. The shipment’s destination…
Most read
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
AACR Report Details Rapid Progress in Targeted Cancer Therapies and Survival
-
Study Links High Sugar Intake to 28% Higher Breast Cancer Risk in Korean Women
-
Dexcom CONNECT Study Shows CGM Lowers A1C by 1.6% in Non-Insulin Type 2 Diabetes
-
How Satri-Cel Became the World’s First Approved Solid Tumor CAR-T
-
Missed NHS England cancer‑treatment target threatens bladder‑cancer surgery waiting times
-
AstraZeneca’s Imfinzi Wins FDA Approval for Bladder Cancer Patients
-
How Kazia’s Nuclear PD-L1 Degrader Aims to Overcome Cancer Resistance
-
FDA RMAT and Fast Track Designations Set New Evidence Bar for Cell Therapies
-
How mRNA Technology Is Transforming the Future of Personalized Cancer Vaccines
-
Workers Can Boost Tax Savings by Maximizing New $3,500 Health FSA Limit for 2027
-
Fidelity’s Shift to Managed Accounts and Private Assets: What It Means for 401(k) Savers
-
How Required Minimum Distributions Work and Strategies to Lower Taxes
-
How the 2027 401(k) Limit Increase to $25,500 Changes Retirement Planning
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992